ATG3 and acute myeloid leukemia: Furthermore, the deletion of ATG3 sensitized AML cells to the inhibition of oxidative phosphorylation (OXPHOS), highlighting the metabolic vulnerabilities that leukemia cells acquire from autophagy inhibition [54].